2023 CTAD Presentation

2023 CTAD Presentation:

 

INTERCEPT-AD phase 1 insights and findings from the investigation of ACU193, a monoclonal antibody targeting soluble Aβ oligomers.

File Type: pdf
File Size: 2 MB
Categories: 2023
Tags: 2023, Amyloid Plaque, ARIA, CTAD, INTERCEPT-AD, Presentation, Target Engagement, TwentyTwentyThree